West Pharmaceutical Services Quarterly Balance Sheet
NYSE: WSTHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:02 PM ET · Delayed 15 min
West Pharmaceutical Services financial position
As of Jun 30, 2026, West Pharmaceutical Services reported total assets of $4.08 billion, up 3.1% from a year earlier against total liabilities of $1.09 billion. Shareholders' equity stood at $2.99 billion, or 73.4% of assets. The company held $435.8 million in cash and equivalents against $202.9 million of debt, a net cash position of $232.9 million.
The current ratio (current assets divided by current liabilities) was 2.82, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.07.
Summary generated from market data by MetaCap's automated system. Methodology
West Pharmaceutical Services balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 435.80M | 521.40M | 791.30M | 628.50M | 509.70M | 404.20M | 484.60M | 490.90M | 446.20M | 601.80M | 853.90M | 898.60M |
| Receivables | 712.00M | 685.60M | 574.40M | 625.00M | 582.40M | 543.60M | 552.50M | 524.30M | 479.40M | 524.00M | 512.00M | 519.10M |
| Inventory | 447.40M | 452.60M | 443.90M | 438.00M | 421.10M | 388.70M | 377.00M | 401.20M | 419.20M | 429.90M | 434.70M | 431.80M |
| Total Current Assets | 1.81B | 1.83B | 1.98B | 1.82B | 1.68B | 1.46B | 1.54B | 1.55B | 1.48B | 1.69B | 1.94B | 1.97B |
| Property, Plant & Equipment | 1.69B | 1.70B | 1.73B | 1.74B | 1.72B | 1.63B | 1.58B | 1.57B | 1.49B | 1.45B | 1.41B | 1.31B |
| Goodwill | 108.70M | 109.20M | 109.90M | 110.60M | 110.90M | 107.50M | 106.00M | 108.80M | 107.30M | 107.60M | 108.50M | 106.80M |
| Intangible Assets | 6.40M | 7.00M | 7.70M | 8.90M | 9.70M | 10.00M | 10.80M | 12.30M | 12.90M | 13.90M | 15.10M | 15.70M |
| Total Assets | 4.08B | 4.11B | 4.27B | 4.11B | 3.95B | 3.62B | 3.64B | 3.68B | 3.49B | 3.60B | 3.83B | 3.75B |
| Accounts Payable | 252.70M | 252.30M | 253.70M | 255.80M | 239.00M | 228.40M | 239.30M | 224.30M | 211.70M | 240.10M | 242.40M | 219.80M |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 132.90M | 133.40M | 134.00M | 55.20M |
| Total Current Liabilities | 640.50M | 674.00M | 654.90M | 635.40M | 604.60M | 526.70M | 550.40M | 516.50M | 633.70M | 648.40M | 671.80M | 533.50M |
| Long-Term Debt | 202.90M | 202.80M | 202.80M | 202.70M | 202.60M | 202.60M | 202.60M | 202.60M | 72.90M | 72.80M | 72.80M | 152.10M |
| Total Liabilities | 1.09B | 1.12B | 1.09B | 1.05B | 1.02B | 935.10M | 961.10M | 923.00M | 912.60M | 921.70M | 948.50M | 886.50M |
| Shareholders' Equity | 2.99B | 2.99B | 3.18B | 3.05B | 2.93B | 2.68B | 2.68B | 2.75B | 2.58B | 2.68B | 2.88B | 2.87B |
| Retained Earnings | 4.62B | 4.48B | 4.37B | 4.26B | 4.14B | 4.03B | 3.96B | 3.86B | 3.72B | 3.62B | 3.52B | 3.42B |
| Total Debt | 202.90M | 202.80M | 202.80M | 202.70M | 202.60M | 202.60M | 202.60M | 202.60M | 205.80M | 206.20M | 206.80M | 207.30M |
| Net Cash (Debt) | 232.90M | 318.60M | 588.50M | 425.80M | 307.10M | 201.60M | 282.00M | 288.30M | 240.40M | 395.60M | 647.10M | 691.30M |
| Shares Outstanding | 70.40M | 70.90M | 72.00M | 71.90M | 71.90M | 71.80M | 72.30M | 72.50M | 72.60M | 73.00M | 73.50M | 74.00M |
This table shows 12 quarterly periods of West Pharmaceutical Services's balance sheet, from Q2 2026 back to Q3 2023, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow WST's reporting calendar. What is a balance sheet?